Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma
2010 ◽
Vol 117
(11)
◽
pp. 2579-2580
◽
Kacey O'Rourke
◽
Kirk Morris
◽
Glen A. Kennedy
2010 ◽
Vol 116
(18)
◽
pp. 4283-4290
◽
Jeremy S. Abramson
◽
Matthew Hellmann
◽
Jeffrey A. Barnes
◽
Peter Hammerman
◽
Christiana Toomey
◽
...
2010 ◽
Vol 117
(11)
◽
pp. 2580-2581
◽
Jeremy S. Abramson
◽
Ephraim P. Hochberg
2019 ◽
Vol 37
◽
pp. 132-132
S. Leppä
◽
J. Jørgensen
◽
A. Tierens
◽
L. Meriranta
◽
I. Østlie
◽
...
Mahender Yellu
◽
Gunjan Guha
◽
Chandana Kamireddy
◽
Zartash Gul
◽
Tahir Latif
2014 ◽
Vol 111
(6)
◽
pp. 1072-1079
◽
C Y Cheah
◽
K E Herbert
◽
K O'Rourke
◽
G A Kennedy
◽
A George
◽
...
2015 ◽
Vol 7
(4)
◽
pp. 160-162
◽
Pooja Advani
◽
Jason Starr
◽
Abhisek Swaika
◽
Liuyan Jiang
◽
Yushi Qiu
◽
...
2010 ◽
Vol 90
(5)
◽
pp. 539-546
◽
Seok Jin Kim
◽
Sung Yong Oh
◽
Jin Seok Kim
◽
Hawk Kim
◽
Gyeong-Won Lee
◽
...
2016 ◽
Vol 27
(suppl_9)
◽
2013 ◽
Vol 2
(1)
◽
pp. 19
◽
Satoshi Ichikawa
◽
Noriko Fukuhara
◽
Ai Inoue
◽
Hiroki Katsushima
◽
Rie Ohba
◽
...
Close
Export Citation Format
Close
Share Document
Close